Cited 11 times since 1994 (0.4 per year) source: EuropePMC Respiration; international review of thoracic diseases, Volume 61, Issue 3, 1 1 1994, Pages 167-168 High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer. Sutedja G, Baris G, van Zandwijk N, Postmus PE
Two patients presented with intraluminal T1N0 squamous cell lung cancer. Poor lung function precluded surgical resection and/or external radiotherapy. They were treated up to 3 times with high-dose rate brachytherapy (10 Gy at 1 cm each session) with curative intent. Follow-up has been 54 and 25 months. Brachytherapy is an effective and well-tolerated bronchoscopic treatment alternative with a curative potential in patients with small T1N0 intraluminal lung cancer.
